Vice President, Medical Affairs at Vir Biotechnology

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, HealthcareIndustries

Requirements

Strategic and hands-on leadership experience in Medical Affairs
Ability to develop and execute strategies aligned with corporate goals
Experience leading teams in Medical Affairs, with potential to build and expand departments
Expertise in hepatitis delta virus (HDV) commercialization readiness and broader portfolio in infectious diseases and oncology
Cross-functional collaboration experience with clinical development, clinical operations, regulatory affairs, commercial, market access, and pharmacovigilance
Location in San Francisco with 3 days per week in office expectation
Leadership reporting to Chief Medical Officer

Responsibilities

Develop and execute global Medical Affairs strategy across all programs and therapeutic areas in alignment with corporate goals and priorities
Partner with clinical development teams on late-stage planning and lead Medical Affairs launch readiness activities
Provide cross-functional leadership and strategic input across clinical development, clinical operations, regulatory affairs, commercial, market access, and pharmacovigilance to inform product development strategies and commercial planning
Oversee operations, budget management, and tactical execution of medical affairs initiatives
Oversee publication strategy and execution
Lead congress and scientific meeting strategy to maximize scientific impact and visibility
Advance collaborations with Key Opinion Leaders and establish robust partnerships within the medical and scientific community, including oversight of KOL interactions, advisory board strategy, academic partnerships, and professional society activities to generate actionable insights
Oversee Medical Science Liaison (MSL) and Medical Information teams to deliver high-quality, compliant scientific exchange
Establish and oversee medical engagement strategies, directing team interactions with HCPs and synthesizing insights to inform organizational strategy and tactics
Oversee the gathering and synthesis of customer insights regarding Vir Bio and competitor products, translating findings into strategic recommendations to inform medical and commercial decision-making
Lead medical education initiatives to support disease state awareness and product knowledge
Serve as a medical and scientific representative of Vir Bio in interaction with external partners, including KOLs, medical experts, government agencies, and patient/provider organizations
Lead, mentor, and develop an existing team of medical affairs professionals, elevating team capabilities and performance to meet evolving business needs
Build a culture of transparency, innovation, teamwork, and scientific excellence
Maintain Medical Affairs excellence through adherence to standards

Skills

Key technologies and capabilities for this role

Medical AffairsStrategic LeadershipLaunch ReadinessHepatitis Delta VirusInfectious DiseasesOncologyTeam LeadershipBudget ManagementMedical EngagementProduct DevelopmentCommercialization

Questions & Answers

Common questions about this position

Is this position remote or does it require office presence?

This position is located in our San Francisco headquarters with an expectation of 3 days per week in office.

What is the salary or compensation for this role?

This information is not specified in the job description.

What are the key responsibilities or skills needed for this Vice President role?

Key responsibilities include developing and executing global Medical Affairs strategy, partnering with clinical development on launch readiness, providing cross-functional leadership, overseeing operations and budget, advancing KOL collaborations, and leading MSL and publication strategies.

What is the company culture like at Vir Biotechnology?

Vir Biotechnology is committed to creating a company where everyone feels supported and encouraged to give their best, believing that the success of colleagues drives the success of the mission.

What makes a strong candidate for this VP Medical Affairs position?

A strong candidate is strategic and hands-on, with leadership experience to lead an established team, build the department, drive launch readiness for HDV and broader portfolio, and provide Medical Affairs expertise across the organization.

Vir Biotechnology

Develops monoclonal antibodies for infectious diseases

About Vir Biotechnology

Vir Biotechnology develops treatments that leverage the immune system to combat infectious diseases. The company uses a proprietary monoclonal antibody platform combined with machine learning to create a database of human antibodies, which aids in developing effective medicines. Their pipeline includes candidates for hepatitis B, hepatitis delta, HIV, and various viruses like influenza and COVID-19. Vir stands out by collaborating with industry leaders and organizations to accelerate scientific advancements, with the goal of transforming lives through innovative therapies.

San Francisco, CaliforniaHeadquarters

2016Year Founded

$640.6MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement

Risks

Leadership instability due to key executive resignations may disrupt operations.

Job cuts and facility closures indicate potential financial strain.

Struggles to diversify beyond COVID-19 antibody success may impact revenue growth.

Differentiation

Vir Biotechnology uses AI-enhanced capabilities for monoclonal antibody development.

The company focuses on immune system manipulation for targeted therapies.

Vir's pipeline includes a potential functional cure for chronic hepatitis B.

Upsides

Increased interest in AI-driven drug discovery benefits Vir's AI capabilities.

The rise of personalized medicine aligns with Vir's monoclonal antibody focus.

Global pandemic preparedness funding supports Vir's broad-spectrum antiviral therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free